Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 4/2005

01-08-2005

Abstracts of selected papers from the current literature

Author: E. Maureen White, M.D.

Published in: Abdominal Radiology | Issue 4/2005

Login to get access

Excerpt

MR colonography: baseline appearance of the unprepared rectosigmoid. V.L. Jardine, E. Sala, D.J. Lomas. Br J Radiol 2005; 78:202–206. (David J Lomas, University Department of Radiology, Box 219, Level 5, Addenbrooke’s Hospital, Cambridge, CB2 2QQ United Kingdom) …
Metadata
Title
Abstracts of selected papers from the current literature
Author
E. Maureen White, M.D.
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 4/2005
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-005-0347-z

Other articles of this Issue 4/2005

Abdominal Radiology 4/2005 Go to the issue

OriginalPaper

Radiofrequency ablation of colorectal liver metastases

Invited update

Gastric cancer by multidetector row CT: preoperative staging

OriginalPaper

CT virtual endoscopy of the stomach: comparison study with gastric fiberscopy

OriginalPaper

A review of the general aspects of radiofrequency ablation

OriginalPaper

Bile duct leaks after laparoscopic cholecystectomy: value of contrast-enhanced MRCP

OriginalPaper

Radiofrequency ablation of renal cell carcinoma
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits